Last 12 months
Inside the activity.
2 purchase rows · 26 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 2 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 5 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2026 Filed Sep 14, 2026 21:19 UTC |
Dadakis AlexSee Remarks
|
GrantRestricted Stock Units · Derivative | 21 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-004174 · form4.xml · derivative · entry 1 Dadakis Alex · CIK 0002053686 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,727 Underlying: Class A Common Stock · 21 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of March 3, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of March 3, 2025. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 21:18 UTC |
D'Angelo ScottEVP, CLO & Corporate Secy
|
GrantRestricted Stock Units · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-004173 · form4.xml · derivative · entry 3 D'Angelo Scott · CIK 0001846183 · EVP, CLO & Corporate Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,866 Underlying: Class A Common Stock · 5 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F5 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2026. F5 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2026. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 21:18 UTC |
D'Angelo ScottEVP, CLO & Corporate Secy
|
GrantRestricted Stock Units · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-004173 · form4.xml · derivative · entry 2 D'Angelo Scott · CIK 0001846183 · EVP, CLO & Corporate Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,403 Underlying: Class A Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of May 1, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of May 1, 2025. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 21:18 UTC |
D'Angelo ScottEVP, CLO & Corporate Secy
|
GrantRestricted Stock Units · Derivative | 11 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-004173 · form4.xml · derivative · entry 1 D'Angelo Scott · CIK 0001846183 · EVP, CLO & Corporate Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,769 Underlying: Class A Common Stock · 11 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of May 1, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of May 1, 2025. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 21:10 UTC |
Chapin Linda SEVP & CHRO
|
GrantRestricted Stock Units · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-004172 · form4.xml · derivative · entry 3 Chapin Linda S · CIK 0001939945 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,843 Underlying: Class A Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F6 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2026. F6 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2026. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 21:10 UTC |
Chapin Linda SEVP & CHRO
|
GrantRestricted Stock Units · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-004172 · form4.xml · derivative · entry 2 Chapin Linda S · CIK 0001939945 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,372 Underlying: Class A Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F5 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2025. F5 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2025. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 21:10 UTC |
Chapin Linda SEVP & CHRO
|
GrantRestricted Stock Units · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-004172 · form4.xml · derivative · entry 1 Chapin Linda S · CIK 0001939945 · EVP & CHRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,468 Underlying: Class A Common Stock · 2 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of May 1, 2024. F3 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of May 1, 2024. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:19 UTC |
Scanlon Jennifer F.Director · President and CEO
|
SaleClass A Common Stock | 2,005 | $74.43 | $149,225.33 |
DisclosureSEC source: 0000905148-26-004071 · form4.xml · nonDerivative · entry 2 Scanlon Jennifer F. · CIK 0001426641 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 139,224 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $74.21 to $74.72, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 01, 2026 Filed Sep 3, 2026 20:19 UTC |
Scanlon Jennifer F.Director · President and CEO
|
SaleClass A Common Stock | 10,495 | $73.52 | $771,574.56 |
DisclosureSEC source: 0000905148-26-004071 · form4.xml · nonDerivative · entry 1 Scanlon Jennifer F. · CIK 0001426641 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,229 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $73.21 to $74.20, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 06, 2026 Filed Aug 10, 2026 20:06 UTC |
Shannon James MDirector
|
GiftClass A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-003547 · form4.xml · nonDerivative · entry 1 Shannon James M · CIK 0001395587 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,542 Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:11 UTC |
Scanlon Jennifer F.Director · President and CEO
|
SaleClass A Common Stock | 5,590 | $92.89 | $519,233.86 |
DisclosureSEC source: 0000905148-26-003480 · form4.xml · nonDerivative · entry 3 Scanlon Jennifer F. · CIK 0001426641 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 151,724 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $92.51 to $93.38, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:11 UTC |
Scanlon Jennifer F.Director · President and CEO
|
SaleClass A Common Stock | 3,281 | $91.89 | $301,492.40 |
DisclosureSEC source: 0000905148-26-003480 · form4.xml · nonDerivative · entry 2 Scanlon Jennifer F. · CIK 0001426641 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 157,314 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $91.51 to $92.50, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:11 UTC |
Scanlon Jennifer F.Director · President and CEO
|
SaleClass A Common Stock | 3,629 | $91.02 | $330,303.60 |
DisclosureSEC source: 0000905148-26-003480 · form4.xml · nonDerivative · entry 1 Scanlon Jennifer F. · CIK 0001426641 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 160,595 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $90.51 to $91.50, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 06, 2026 Filed Jul 9, 2026 00:51 UTC |
Kini VikramDirector
|
GrantDeferred Stock Units · Derivative | 213 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-003188 · form4.xml · derivative · entry 1 Kini Vikram · CIK 0001815604 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 437 Underlying: Class A Common Stock · 213 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. F2 · derivative.expiration_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. Read SEC document |
| July 06, 2026 Filed Jul 9, 2026 00:52 UTC |
THAMAN MICHAEL HDirector
|
GrantDeferred Stock Units · Derivative | 340 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-003189 · form4.xml · derivative · entry 1 THAMAN MICHAEL H · CIK 0001228309 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 698 Underlying: Class A Common Stock · 340 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the right to receive one share of the Issuer's Class A Common Stock. F2 · derivative.exercise_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. F2 · derivative.expiration_date: The deferred stock units are fully vested and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. Read SEC document |
| July 01, 2026 Filed Jul 3, 2026 00:13 UTC |
Scanlon Jennifer F.Director · President and CEO
|
SaleClass A Common Stock | 300 | $101.74 | $30,522.99 |
DisclosureSEC source: 0000905148-26-003153 · form4.xml · nonDerivative · entry 5 Scanlon Jennifer F. · CIK 0001426641 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 164,224 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F6 · price: This transaction was executed in multiple trades at prices ranging from $101.63 to $101.89, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2026 Filed Jul 3, 2026 00:13 UTC |
Scanlon Jennifer F.Director · President and CEO
|
SaleClass A Common Stock | 2,600 | $101.05 | $262,731.04 |
DisclosureSEC source: 0000905148-26-003153 · form4.xml · nonDerivative · entry 4 Scanlon Jennifer F. · CIK 0001426641 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 164,524 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F5 · price: This transaction was executed in multiple trades at prices ranging from $100.62 to $101.58, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2026 Filed Jul 3, 2026 00:13 UTC |
Scanlon Jennifer F.Director · President and CEO
|
SaleClass A Common Stock | 1,200 | $100.34 | $120,409.44 |
DisclosureSEC source: 0000905148-26-003153 · form4.xml · nonDerivative · entry 3 Scanlon Jennifer F. · CIK 0001426641 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 167,124 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F4 · price: This transaction was executed in multiple trades at prices ranging from $99.60 to $100.58, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2026 Filed Jul 3, 2026 00:13 UTC |
Scanlon Jennifer F.Director · President and CEO
|
SaleClass A Common Stock | 3,600 | $99.05 | $356,576.04 |
DisclosureSEC source: 0000905148-26-003153 · form4.xml · nonDerivative · entry 2 Scanlon Jennifer F. · CIK 0001426641 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,324 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F3 · price: This transaction was executed in multiple trades at prices ranging from $98.54 to $99.53, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2026 Filed Jul 3, 2026 00:13 UTC |
Scanlon Jennifer F.Director · President and CEO
|
SaleClass A Common Stock | 4,800 | $97.92 | $470,037.12 |
DisclosureSEC source: 0000905148-26-003153 · form4.xml · nonDerivative · entry 1 Scanlon Jennifer F. · CIK 0001426641 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 171,924 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 9, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $97.50 to $98.47, inclusive. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 09, 2026 Filed Jun 10, 2026 21:22 UTC |
PEPPING KAREN KSenior VP & CAO
|
SaleClass A Common Stock | 725 | $97.74 | $70,861.50 |
DisclosureSEC source: 0000905148-26-002894 · form4.xml · nonDerivative · entry 1 PEPPING KAREN K · CIK 0001369818 · Senior VP & CAO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,082 F1 · kind: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2026. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:16 UTC |
Dadakis AlexSee Remarks
|
GrantRestricted Stock Units · Derivative | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002885 · form4.xml · derivative · entry 3 Dadakis Alex · CIK 0002053686 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,920 Underlying: Class A Common Stock · 8 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F6 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2026. F6 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2026. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:16 UTC |
Dadakis AlexSee Remarks
|
GrantRestricted Stock Units · Derivative | 5 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002885 · form4.xml · derivative · entry 2 Dadakis Alex · CIK 0002053686 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,487 Underlying: Class A Common Stock · 5 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F5 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2025. F5 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2025. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:16 UTC |
Dadakis AlexSee Remarks
|
GrantRestricted Stock Units · Derivative | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002885 · form4.xml · derivative · entry 1 Dadakis Alex · CIK 0002053686 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,706 Underlying: Class A Common Stock · 15 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of March 3, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of March 3, 2025. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:29 UTC |
Torstad ElisabethDirector
|
GrantDeferred Restricted Stock Units · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002901 · form4.xml · derivative · entry 3 Torstad Elisabeth · CIK 0001997462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,209 Underlying: Class A Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person. F6 · derivative.exercise_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan. F6 · derivative.expiration_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan. F4 · balance_after: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:29 UTC |
Torstad ElisabethDirector
|
GrantDeferred Restricted Stock Units · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002901 · form4.xml · derivative · entry 2 Torstad Elisabeth · CIK 0001997462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,809 Underlying: Class A Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person. F5 · derivative.exercise_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan. F5 · derivative.expiration_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan. F4 · balance_after: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:29 UTC |
Torstad ElisabethDirector
|
GrantDeferred Restricted Stock Units · Derivative | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002901 · form4.xml · derivative · entry 1 Torstad Elisabeth · CIK 0001997462 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,969 Underlying: Class A Common Stock · 7 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. F3 · derivative.expiration_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. F4 · balance_after: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:18 UTC |
Hancock Lynn HSee Remarks
|
GrantRestricted Stock Units · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002889 · form4.xml · derivative · entry 4 Hancock Lynn H · CIK 0001939809 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,579 Underlying: Class A Common Stock · 2 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F7 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2026. F7 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2026. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:18 UTC |
Hancock Lynn HSee Remarks
|
GrantRestricted Stock Units · Derivative | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002889 · form4.xml · derivative · entry 3 Hancock Lynn H · CIK 0001939809 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,548 Underlying: Class A Common Stock · 2 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F6 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2025. F6 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2025. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:18 UTC |
Hancock Lynn HSee Remarks
|
GrantRestricted Stock Units · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002889 · form4.xml · derivative · entry 2 Hancock Lynn H · CIK 0001939809 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,029 Underlying: Class A Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F5 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of January 1, 2025. F5 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of January 1, 2025. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:18 UTC |
Hancock Lynn HSee Remarks
|
GrantRestricted Stock Units · Derivative | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002889 · form4.xml · derivative · entry 1 Hancock Lynn H · CIK 0001939809 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,305 Underlying: Class A Common Stock · 1 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of May 1, 2024. F3 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of May 1, 2024. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:14 UTC |
D'Angelo ScottEVP, CLO & Corporate Secy
|
GrantRestricted Stock Units · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002884 · form4.xml · derivative · entry 3 D'Angelo Scott · CIK 0001846183 · EVP, CLO & Corporate Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,861 Underlying: Class A Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F5 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2026. F5 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2026. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:14 UTC |
D'Angelo ScottEVP, CLO & Corporate Secy
|
GrantRestricted Stock Units · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002884 · form4.xml · derivative · entry 2 D'Angelo Scott · CIK 0001846183 · EVP, CLO & Corporate Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,399 Underlying: Class A Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of May 1, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of May 1, 2025. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:14 UTC |
D'Angelo ScottEVP, CLO & Corporate Secy
|
GrantRestricted Stock Units · Derivative | 8 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002884 · form4.xml · derivative · entry 1 D'Angelo Scott · CIK 0001846183 · EVP, CLO & Corporate Secy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,758 Underlying: Class A Common Stock · 8 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of May 1, 2025. F3 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of May 1, 2025. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:21 UTC |
Kini VikramDirector
|
GrantRestricted Stock Units · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002893 · form4.xml · derivative · entry 1 Kini Vikram · CIK 0001815604 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,209 Underlying: Class A Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date. F3 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:20 UTC |
KENNEDY KEVINDirector
|
GrantRestricted Stock Units · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002892 · form4.xml · derivative · entry 3 KENNEDY KEVIN · CIK 0001182379 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,209 Underlying: Class A Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F6 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F7 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date. F7 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date. F8 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:20 UTC |
KENNEDY KEVINDirector
|
GrantDeferred Restricted Stock Units · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002892 · form4.xml · derivative · entry 2 KENNEDY KEVIN · CIK 0001182379 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,809 Underlying: Class A Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person. F5 · derivative.exercise_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan. F5 · derivative.expiration_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan. F4 · balance_after: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:20 UTC |
KENNEDY KEVINDirector
|
GrantDeferred Restricted Stock Units · Derivative | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002892 · form4.xml · derivative · entry 1 KENNEDY KEVIN · CIK 0001182379 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,969 Underlying: Class A Common Stock · 7 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. F3 · derivative.expiration_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. F4 · balance_after: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:23 UTC |
Scanlon Jennifer F.Director · President and CEO
|
GrantRestricted Stock Units · Derivative | 54 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002896 · form4.xml · derivative · entry 3 Scanlon Jennifer F. · CIK 0001426641 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,509 Underlying: Class A Common Stock · 54 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F6 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2026. F6 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2026. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:23 UTC |
Scanlon Jennifer F.Director · President and CEO
|
GrantRestricted Stock Units · Derivative | 42 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002896 · form4.xml · derivative · entry 2 Scanlon Jennifer F. · CIK 0001426641 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,576 Underlying: Class A Common Stock · 42 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F5 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2025. F5 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2025. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:23 UTC |
Scanlon Jennifer F.Director · President and CEO
|
GrantRestricted Stock Units · Derivative | 32 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002896 · form4.xml · derivative · entry 1 Scanlon Jennifer F. · CIK 0001426641 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,454 Underlying: Class A Common Stock · 32 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of May 1, 2024. F3 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of May 1, 2024. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:26 UTC |
SUSMAN SALLYDirector
|
GrantRestricted Stock Units · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002899 · form4.xml · derivative · entry 3 SUSMAN SALLY · CIK 0001263544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,209 Underlying: Class A Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F6 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F7 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date. F7 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date. F8 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:26 UTC |
SUSMAN SALLYDirector
|
GrantDeferred Restricted Stock Units · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002899 · form4.xml · derivative · entry 2 SUSMAN SALLY · CIK 0001263544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,809 Underlying: Class A Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person. F5 · derivative.exercise_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan. F5 · derivative.expiration_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan. F4 · balance_after: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:26 UTC |
SUSMAN SALLYDirector
|
GrantDeferred Restricted Stock Units · Derivative | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002899 · form4.xml · derivative · entry 1 SUSMAN SALLY · CIK 0001263544 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,969 Underlying: Class A Common Stock · 7 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") and deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. F3 · derivative.expiration_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. F4 · balance_after: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:17 UTC |
GOTTSCHALK MARLA CDirector
|
GrantDeferred Restricted Stock Units · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002888 · form4.xml · derivative · entry 3 GOTTSCHALK MARLA C · CIK 0001241912 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,209 Underlying: Class A Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person. F6 · derivative.exercise_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan. F6 · derivative.expiration_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan. F4 · balance_after: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:17 UTC |
GOTTSCHALK MARLA CDirector
|
GrantDeferred Restricted Stock Units · Derivative | 4 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002888 · form4.xml · derivative · entry 2 GOTTSCHALK MARLA C · CIK 0001241912 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,809 Underlying: Class A Common Stock · 4 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person. F5 · derivative.exercise_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan. F5 · derivative.expiration_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 20, 2026, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan. F4 · balance_after: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:17 UTC |
GOTTSCHALK MARLA CDirector
|
GrantDeferred Restricted Stock Units · Derivative | 7 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002888 · form4.xml · derivative · entry 1 GOTTSCHALK MARLA C · CIK 0001241912 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,969 Underlying: Class A Common Stock · 7 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. F3 · derivative.expiration_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vested on May 1, 2025, and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Non-Employee Director Deferred Compensation Plan (the "Plan"), or (ii) as otherwise provided by the Plan. F4 · balance_after: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:27 UTC |
THAMAN MICHAEL HDirector
|
GrantDeferred Restricted Stock Units · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002900 · form4.xml · derivative · entry 1 THAMAN MICHAEL H · CIK 0001228309 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,209 Underlying: Class A Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on DRSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan. F3 · derivative.expiration_date: The dividend equivalent rights accrued on DRSUs held by the Reporting Person and vest proportionately with the DRSUs to which they relate. The DRSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date and will be settled in shares of the Issuer's Class A Common Stock either (i) on a date selected by the Reporting Person pursuant to the Issuer's Plan, or (ii) as otherwise provided by the Plan. F4 · balance_after: Includes DRSUs and all dividend equivalent rights that have accrued on such DRSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:16 UTC |
DOLLIVE JAMES PDirector
|
GrantRestricted Stock Units · Derivative | 3 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002886 · form4.xml · derivative · entry 1 DOLLIVE JAMES P · CIK 0001192477 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,209 Underlying: Class A Common Stock · 3 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F3 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date. F3 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest on the earlier of May 20, 2027, or the date of the annual meeting following the May 20, 2026, grant date. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 21:22 UTC |
Robinson Ryan DExecutive VP & CFO
|
GrantRestricted Stock Units · Derivative | 13 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002895 · form4.xml · derivative · entry 3 Robinson Ryan D · CIK 0001324494 · Executive VP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,880 Underlying: Class A Common Stock · 13 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2 · shares: Represents accrual of dividend equivalent rights on RSUs held by the Reporting Person. F6 · derivative.exercise_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2026. F6 · derivative.expiration_date: The dividend equivalent rights accrued on RSUs held by the Reporting Person and vest proportionately with the RSUs to which they relate. The RSUs vest in three equal installments on the first, second and third anniversaries of April 1, 2026. F4 · balance_after: Includes RSUs and all dividend equivalent rights that have accrued on such RSUs to date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.